Table 1.
Study end points
Assay | Reagent | Time point | |
---|---|---|---|
Primary end point | Peak thrombin generation | PPP‐reagent low (Stago) | 30 min after Kcentra/placebo infusion |
Secondary end points |
|
|
30 min after Kcentra/placebo infusion and 0–72 h |
Chromogenic anti‐factor Xa | Biophen Heparin (Anaria) | ||
PT | PT reagent (Instrumentation Laboratory) | ||
PTT | APTT reagent (Instrumentation Laboratory) |
mVRI, mean velocity rate index; PT, prothrombin time; PTT, partial thromboplastin time.